Have a personal or library account? Click to login
Acute Kidney Injury after Liver Transplantation Cover

References

  1. HŮLEK, P, a kol. Hepatologie. 3. vyd. Praha: Grada Publishing, 2018. ISBN 978-80-271-0394
  2. KIM, W.R., et al. OPTN/SRTR 2012 Annual Data Report: liver. American Journal of transplantation. 2014, 14(Suppl 1), 69–96. ISSN 1600-6135.
  3. DURAND, F., et al. Acute kidney injury after liver transplantation. Transplantation. 2018, 102(10), 1636–1649. ISSN 0041-1337.
  4. ANGELI, P., et al. Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the International Club of Ascites. Journal of hepatology. 2015, 62(4), 968–974. ISSN 0168-8278.
  5. GINÈS, P., et al. Hepatorenal syndrome. Nature reviews. Disease primers. 2018, 4(1), 23. ISSN 2056-676X.
  6. AMIN, A.A. et al. Epidemiology, pathophysiology, and management of hepatorenal syndrome. Seminars in nephrology. 2019, 39(1), 17–30. ISSN 0270-9295.
  7. ALLEGRETTI, A.S., et al. Prognosis of acute kidney injury and hepatorenal syndrome in patients with cirrhosis: a prospective cohort study. International journal of nephrology. 2015, 2015, 108139. ISSN 2090-214X.
  8. GOREN, O., et al. Update on perioperative acute kidney injury. Current opinion in critical care. 2016, 22(4), 370–378. ISSN 1070-5295.
  9. AGGARWAL, S., et al. Postreperfusion syndrome: hypotension after reperfusion of the transplanted liver. Journal of critical care. 1993, 8(3), 154–160. ISSN 0883-9441.
  10. BRESCIA, M.D., et al. Prospective randomized trial comparing hepatic venous outflow and renal function after conventional versus piggyback liver transplantation. PLoS one. 2015, 10(6), e0129923. ISSN 1932-6203.
  11. DE HAAN, J.E., et al. Acute kidney injury after liver transplantation: Recent insights and future perspectives. Best practice & research. Clinical gastroenterology. 2017, 31(2), 161–169. ISSN 1521-6918.
  12. YOO, S., et al. Association between perioperative hyperglycemia or glucose variability and postoperative acute kidney injury after liver transplantation: a retrospective observational study. Anesthesia and analgesia. 2017, 124(1), 35–41. ISSN 0003-2999.
  13. NADIM, M.K., et al. Intraoperative hemodialysis during liver transplantation: a decade of experience. Liver transplantation. 2014, 20(7), 756–764. ISSN 1527-6465.
  14. WADEI, H.M., et al. Early allograft dysfunction after liver transplantation is associated with short- and long-term kidney function impairment. American journal of transplantation. 2016, 16(3), 850–859. ISSN 1600-6135.
  15. NEVENS, F., et al. Renal disease in the allograft recipient. Best practice & research. Clinical gastroenterology. 2020, 46–47, 101690. ISSN 1521-6918.
  16. PILLEBOUT, E., et al. Renal histopathological lesions after orthotopic liver transplantation (OLT). American journal of transplantation. 2005, 5(5), 1120–1129. ISSN 1600-6135.
  17. BOUCHARD, J., et al. Fluid accumulation, survival and recovery of kidney function in critically ill patients with acute kidney injury. Kidney international. 2009, 76(4), 422–427. ISSN 0085-2538.
  18. OJO, A.O., et al. Chronic renal failure after transplantation of a nonrenal organ. New England journal of medicine. 2003, 349(10), 931–940. ISSN 0028-4793.
  19. FUSSNER, L.A., et al. The impact of gender and NASH on chronic kidney disease before and after liver transplantation. Liver international. 2014, 34(8), 1259–1266. ISSN 1478-3223.
  20. COLLIOU, É., et al. Kidney failure after liver transplantation. Transplantology. 2021, 2(3), 315–335. ISSN 2673-3943.
  21. CANZANELLO, V.J., et al. Late hypertension after liver transplantation: a comparison of cyclosporine and tacrolimus (FK 506). Liver transplantation and surgery. 1998, 4(4), 328–334. ISSN 1074-3022.
  22. PHAM, P.T., et al. New onset diabetes after transplantation (NODAT): an overview. Diabetes, metabolic syndrome and obesity. 2011, 4, 175–186. ISSN 1178-7007.
  23. KUO, H.T., et al. Risk factors for new-onset diabetes mellitus in adult liver transplant recipients, an analysis of the Organ Procurement and Transplant Network/United Network for Organ Sharing database. Transplantation. 2010, 89(9), 1134–1140. ISSN 0041-1337.
  24. FUSSNER, L.A., et al. Cardiovascular disease after liver transplantation: when, what, and who is at risk. Liver transplantation. 2015, 21(7), 889–896. ISSN 1527-6465.
  25. BIANCHI, G., et al. Metabolic syndrome in liver transplantation: relation to etiology and immunosuppression. Liver transplantation. 2008, 14(11), 1648–1654. ISSN 1527-6465.
  26. ROY, A., et al. Tacrolimus as intervention in the treatment of hyperlipidemia after liver transplant. Transplantation. 2006, 82(4), 494–500. ISSN 0041-1337.
  27. ESLAM, M., et al. A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement. Journal of hepatology. 2020, 73(1), 202–209. ISSN 0168-8278.
  28. MANTOVANI, A., et al. Nonalcoholic fatty liver disease increases risk of incident chronic kidney disease: a systematic review and meta-analysis.Metabolism: clinical and experimental. 2018, 79, 64–76. ISSN 0026-0495.
  29. CABANDUGAMA, P.K., et al. The renin angiotensin aldosterone system in obesity and hypertension: roles in the cardiorenal metabolic syndrome. Medical clinics of North America. 2017, 101(1), 129–137. ISSN 0025-7125.
  30. MASSY, Z.A., et al. The role of oxidative stress in chronic kidney disease. Seminars in dialysis. 2009, 22(4), 405–408. ISSN 0894-0959.
  31. SHARMA, P., et al. Chronic kidney disease and related long-term complications after liver transplantation. Advances in chronic kidney disease. 2015, 22(5), 404–411. ISSN 1548-5595.
  32. ARROYO, V., et al. Acute-on-chronic liver failure in cirrhosis. Nature reviews. Disease primers. 2016, 2, 16041. ISSN 2056-676X.
  33. GALLON, L., et al. ACE gene D/D genotype as a risk factor for chronic nephrotoxicity from calcineurin inhibitors in liver transplant recipients. Transplantation. 2006, 81(3), 463–468. ISSN 0041-1337.
  34. LEVITSKY, J., et al. Protecting the kidney in liver transplant recipients: practice-based recommendations from the American Society of Transplantation Liver and Intestine Community of Practice. American journal of transplantation. 2016, 16(9), 2532–2544. ISSN 1600-6135.
  35. TESAŘ, V., et al. Klinická nefrologie. 2., zcela přeprac. a dopl. vyd. Praha: Grada Publishing, 2015. ISBN 978-80-247-4367-7.
  36. PORTAL, A.J., et al. Neutrophil gelatinase--associated lipocalin predicts acute kidney injury in patients undergoing liver transplantation. Liver transplantation. 2010, 16(11), 1257–1266. ISSN 1527-6465.
  37. CULLARO, G., et al. Early postoperative neutrophil gelatinase-associated lipocalin predicts the development of chronic kidney disease after liver transplantation. Transplantation. 2018, 102(5), 809–815. ISSN 0041-1337.
  38. SHAFFI, K., et al. Performance of creatinine-based GFR estimating equations in solid-organ transplant recipients. American journal of kidney diseases. 2014, 63(6), 1007–1018. ISSN 0272-6386.
  39. ASRANI, S.K., et al. A model for glomerular filtration rate assessment in liver disease (GRAIL) in the presence of renal dysfunction. Hepatology. 2019, 69(3), 1219–1230. ISSN 0270-9139.
  40. BAHIRWANI, R., et al. Outcomes after liver transplantation: chronic kidney disease. Liver transplantation. 2009, 15(Suppl 2), S70–S74. ISSN 1527-6465.
  41. KUBAL, C., et al. Chronic kidney disease after nonrenal solid organ transplantation: a histological assessment and utility of chronic allograft damage index scoring. Transplantation. 2012, 93(4), 406–411. ISSN 0041-1337.
  42. CAVALLIN, M., et al. Terlipressin given by continuous intravenous infusion versus intravenous boluses in the treatment of hepatorenal syndrome: a randomized controlled study. Hepatology. 2016, 63(3), 983–992. ISSN 0270-9139.
  43. PIANO, S., et al. Response to terlipressin and albumin is associated with improved liver transplant outcomes in patients with hepatorenal syndrome. Hepatology. 2021, 73(5), 1909–1919. ISSN 0270-9139.
  44. NADIM, M.K., et al. Management of the critically ill patient with cirrhosis: a multidisciplinary perspective. Journal of hepatology. 2016, 64(3), 717–735. ISSN 0168-8278.
  45. EUROPEAN ASSOCIATION FOR THE STUDY OF THE LIVER. EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis. Journal of hepatology. 2018, 69(2), 406–460. ISSN 0168-8278.
  46. MILLSON, C., et al. Adult liver transplantation: UK clinical guideline - part 2: surgery and postoperation. Frontline gastroenterology. 2020, 11(5), 385–396. ISSN 2041-4137.
  47. Atthota S, Joyal K, Cote Ma, et al. Modern glucose-lowering drugs in liver transplant recipients: improvement in weight, glycemic control, and potentially allograft steatosis Frontiers in Transplantation. Volume 2.2023, doi:10.3389/frtra.2023.1223169. ISSN 2813–2440
  48. CHARLTON, M., et al. Everolimus is associated with less weight gain than tacrolimus 2 years after liver transplantation: results of a randomized multicenter study. Transplantation. 2017, 101(12), 2873–2882. ISSN 0041-1337.
  49. SALIBA, F., et al. Time to conversion to an everolimus-based regimen: renal outcomes in liver transplant recipients from the EVEROLIVER registry. Liver transplantation. 2020, 26(11), 1465–1476. ISSN 1527-6465.
DOI: https://doi.org/10.2478/acm-2024-0009 | Journal eISSN: 1338-4139 | Journal ISSN: 1335-8421
Language: English
Page range: 66 - 74
Submitted on: Feb 27, 2024
|
Accepted on: Jun 17, 2024
|
Published on: Aug 31, 2024
Published by: Sciendo
In partnership with: Paradigm Publishing Services
Publication frequency: 3 issues per year

© 2024 Konkolova Martina, Skladany Lubomir, Cellar Marcel, Kleinova Patricia, Blichova Timea, Beliancinova Monika, Granak Karol, Dedinska Ivana, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.